Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 28,819 |
|
|||||
| News | - | ||||||
| Day High | 5.45 | Low High |
|||||
| Day Low | 5.35 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Capricor Therapeutics Inc | CAPR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.035 | -0.64% | 5.445 | 09:08:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.38 | 5.35 | 5.45 | 5.48 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 97 | 28,819 | US$ 5.37 | US$ 154,858 | - | 2.68 - 8.2212 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:11:02 | 1 | US$ 5.445 | USD |
Capricor Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 169.87M | 31.40M | - | 25.18M | -22.29M | -0.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Capricor Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CAPR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.57 | 6.15 | 5.35 | 5.69 | 416,602 | -0.125 | -2.24% |
| 1 Month | 5.42 | 6.5336 | 5.00 | 5.77 | 406,472 | 0.025 | 0.46% |
| 3 Months | 6.20 | 7.28 | 4.685 | 5.89 | 385,256 | -0.755 | -12.18% |
| 6 Months | 3.33 | 7.28 | 3.2446 | 5.31 | 318,227 | 2.12 | 63.51% |
| 1 Year | 4.69 | 8.2212 | 2.68 | 4.90 | 253,072 | 0.755 | 16.10% |
| 3 Years | 3.90 | 8.2212 | 2.56 | 4.66 | 257,314 | 1.55 | 39.62% |
| 5 Years | 3.00 | 12.32 | 0.88 | 5.92 | 764,698 | 2.45 | 81.50% |
Capricor Therapeutics Description
| Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. |
